Author:
Guo Sha,Yu Chuanfei,Guo Xiao,Jia Zhe,Yu Xiaojuan,Yang Yalan,Guo Luyun,Wang Lan
Reference26 articles.
1. FDA. Annex 3(R1) test for particulate contamination: subvisible particles general chapter guidance for industry. 2017. Available at: https://www.fda.gov/media/71231/download. Accessed September 7, 2020.
2. Particulate matter in injectable drug products;Langille;PDA J Pharm Sci Technol,2013
3. Particulate Matter in Injections,2018
4. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality;Carpenter;J Pharm Sci,2009
5. Characterization and quantitation of aggregates and particles in interferon-beta products: potential links between product quality attributes and immunogenicity;Barnard;J Pharm Sci,2013
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献